amitriptyline has been researched along with Nocturnal Wandering in 3 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bahro, M | 1 |
Katzmann, KJ | 1 |
Gückel, F | 1 |
Sungurtekin, I | 1 |
Riemann, D | 1 |
Ferrándiz-Santos, JA | 1 |
Mataix-Sanjuan, AL | 1 |
Huapaya, LV | 1 |
3 other studies available for amitriptyline and Nocturnal Wandering
Article | Year |
---|---|
[REM sleep parasomnia].
Topics: Amitriptyline; Brain Stem; Carbamazepine; Cerebral Infarction; Dreams; Drug Therapy, Combination; Hu | 1994 |
Amitriptyline and somnambulism.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Female; Humans; Middle Aged; Somnambulism | 2000 |
Seven cases of somnambulism induced by drugs.
Topics: Adult; Alcoholism; Amitriptyline; Chlorprothixene; Depression; Drug Therapy, Combination; Ethchlorvy | 1979 |